Analytical Data
-
Gene name
SSR2
- Application
-
Alternative Names
SSTR2;Somatostatin receptor type 2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P43308
-
Expression Region
18-149aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSEEGARLL ASKSLLNRYA VEGRDLTLQY NIYNVGSSAA LDVELSDDSF PPEDFGIVSG MLNVKWDRIA PASNVSHTVV LRPLKAGYFN FTSATITYLA QEDGPVVIGS TSAPGQGGIL AQREFDRRFS PHFLD
-
Molecular Weight
17 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SSR2, or Secretory System Protein 2, is an essential component of the eukaryotic secretory pathway, particularly involved in protein folding and processing within the endoplasmic reticulum (ER). Recent research has highlighted its critical role in maintaining cellular homeostasis and the proper functioning of the secretory apparatus. Understanding SSR2's structure and function is vital for elucidating its mechanisms in various physiological and pathological contexts, including diseases associated with protein misfolding and ER stress. Studies have shown that SSR2 interacts with other chaperones and enzymes to facilitate the maturation of glycoproteins, thus contributing to the overall efficiency of protein trafficking. Furthermore, SSR2's involvement in potential disease mechanisms, such as in certain neurodegenerative disorders and cancers, underscores its relevance as a target for therapeutic intervention. The study of SSR2 recombinant proteins has emerged as a promising area of research, enabling scientists to investigate its properties, interactions, and potential as a biomarker or therapeutic target. Advancements in recombinant DNA technology allow for the production of SSR2 in various systems, providing insights into its biological function and potential applications in drug development and disease treatment. Overall, the exploration of SSR2 and its recombinant forms offers significant potential for enhancing our understanding of cellular transport processes and developing strategies to combat diseases linked to defects in the secretory pathway.
